ATL Ultrasound will be able to bundle sales of the SonoSite 180 handheld ultrasound system with its own ultrasound systems, thanks to a contract revision signed this month.The agreement removes an exclusivity provision of a January 1999 contract and
ATL Ultrasound will be able to bundle sales of the SonoSite 180 handheld ultrasound system with its own ultrasound systems, thanks to a contract revision signed this month.
The agreement removes an exclusivity provision of a January 1999 contract and enables ATL, a Philips Medical Systems company, to include the SonoSite 180 system with sales of its ultrasound systems. In addition, it allows SonoSite to sell products to private offices as well as hospitals.
The agreement was necessary because SonoSite restructured a distribution contract with PSS World Medical that was signed last year. SonoSite struck an exclusive distributor agreement with PSS World Medical subsidiary Diagnostic Imaging for SonoSite 180 in the private-practice market (SCAN 8/4/99).
ATL produces a line of ultrasound machines called HDI, for high definition imaging, while SonoSite develops, sells, and manufactures a 5-pound handheld digital ultrasound system. The SonoSite 180 system was developed using licensed ATL technology and part of the SonoSite system is manufactured by ATL, said Tim Mickelson, president and CEO of ATL Ultrasound.
The 19 member countries of NATO will purchase the SonoSite 180 handheld ultrasound system for use on the battlefield (SCAN 4/12/00).
SonoSite and ATL Ultrasound signed a similar agreement in March of this year giving ATL exclusive rights to include SonoSite's SonoHeart handheld echocardiology device with sales of its own HDI ultrasound systems and with cardiac catheterization systems from Philips Medical Systems. The SonoHeart agreement covers the distribution of products in cardiology-related segments worldwide, with the exception of Japan. Distribution in Japan is covered under an agreement with Olympus Optical.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.